Expression of adhesion molecules in endemic and epidemic Kaposi's sarcoma

Histopathology

Volumn 29, Issue 4, 1996, Pages 337-346

  Kaaya, E E ^a   Castanos Velez E ^a,b   Amir, H ^c   Lema, L ^c   Luande, J ^c   Kitinya, J ^c   Patarroyo, M ^b   Biberfeld, P ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

Cell adhesion molecules; Extracellular matrix proteins; Kaposi's sarcoma

Indexed keywords

CELL ADHESION MOLECULE; COLLAGEN; CYTOKINE; FIBRONECTIN; INTEGRIN; LAMININ; TENASCIN; THROMBOSPONDIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; PRIORITY JOURNAL; SPINDLE CELL;

EID: 0029797974     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.1996.tb01417.x     Document Type: Article

References (33)

1. Beral V. Epidemiology of Kaposi's sarcoma. Cancer Surveys 1991; 10; 5-22.
2. Slavin G, Cameroon HMcD, Singh H. Kaposi's Sarcoma in Mainland Tanzania: A report of 117 cases. Br. J Cancer 1969; 21; 349-357.
3. Penn I. Kaposi's sarcoma in organ transplant recipients. Transplantation 1979; 27; 8-11.
4. Buchbinder A, Friedman-Kien AE. Clinical aspects of epidemic Kaposi's sarcoma. Cancer Surveys 1991; 10; 39-52.
5. Kaaya EE, Parravicini C, Sundelin B et al. Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma. Eur. J. Cancer 1992 28 A: 1890-1894.
6. O'Connell KA. Resolution of Kaposi's sarcoma. Lancet 1994; 343; 741.
7. Biberfeld P, Nakamura S, Ensoli B et al. Autocrine and paracrine mechanisms in the evolution of Kaposi's sarcoma (KS). In Westermark B. Bersholtz C. Hökefelt B. eds. Growth Factors in Health and Disease. Basic and clinical aspects. Nordisk Insulin Symposium no. 4, Excerpta Medica. Int. Congress Series. Elsevier: Amsterdam, 1990; 925; 277-280.
8. Costa J & Rabson AS. Generalised Kaposi's sarcoma is not a neoplasm., Lancet, 1983; 1; 58.
9. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346; 425-434.
10. Patarroyo M. Leukocyte adhesion in host defense and tissue injury. Clin. Immunol. Immunopath. 1991; 60; 333-348.
11. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J. 1992; 6; 2591-2599.
12. Hynes RO. Integrins-versatility, modulation and signalling in cell adhesion. Cell 1992; 69; 11-25.
13. Weeks BS, Desai K, Lowenstein PM et al. Identification of a novel cell attachment domain in the HIV-tat protein and its 90-kDa cell surface binding protein. J. Cell Biochem. 1993; 268; 5279-5284.
14. Barillari G, Gendelman R, Gallo RC & Ensoli B. The tat protein of human immunodeficiency virus type 1. a growth factor for AIDS Kaposi's sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognising the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 1993; 90; 7941-7945.
15. Vogel BE, Lee S-J, Hildebrand A et al. A novel integrin specificity exemplified by binding of the αVβ5 integrin to the basic domain of the HIV tat protein and vitronectin. J. Cell Biol. 1993; 121; 461-468.
16. Ensoli B, Gallo RC. Growth factors in AIDS-associated Kaposi's sarcoma: Cytokine and HIV-1 tat protein. In De Vita VT. Hellman S. Rosenberg SA. eds, AIDS updates. Piladelphia: JB Lippincott. 1994; 7; 1-12.
17. Giancoti FG, Ruoslahti E. Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 1990; 60; 849-859.
18. Barillari G, Buonaguro L, Fiorelli V et al. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol. 1992; 149; 3727-3734.
19. Kaaya EE, Parravicini C Gendelman R, Berti E, Gallo RC, Biberfeld P. Heterogeneity of spindle cells in Kaposi's sarcoma: Comparison of cell phenotypes in vivo and in vitro. AIDS 1995: in press.
20. Brooks PC, Clark RAF, Cheresh DA. Requirement of vascular integrin αVβ3 for angiogenesis. Science 1994; 264; 569-571.
21. Uccini S, Ruco LP, Monardo F et al. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J. Pathol. 1994; 173; 23-31.
22. Huang V, Friedman-Kien A, Li J, Nickoloff B. Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14 and VCAM-1 but not factor VIII or ELAM-1. Arch. Dermatol. 1993; 129; 1291-1296.
23. Swerlick RA, Kwang HL, Li L et al. Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J. Immunol. 1992; 149; 698-705.
24. Becker J, Schuppan D, Reichart P. The extra cellular matrix in oral Kaposi's sarcoma (AIDS): the immunohistochemical distribution of collagens type IV, V, VI, of procollagen type 1 and III. of laminin and undulin. Virchows Arch. A 1987; 412; 161-168.
25. Bourdon MA, Ruoslahti E. Tenascin mediates cell attachment through an RGD-dependenl receptor. J. Cell Biol. 1989; 108; 1149-1155.
26. Nickoloff BJ, Mitra RS, Varani J et al. Aberrant production of Interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am. J. Pathol. 1994; 155; 820-828.
27. DiPietro LA, Polverini PJ. Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. Am. J. Pathol. 1993; 143; 678-684.
28. Tuszynski GP, Gasic TB, Rothman VL, Knudsen KA, Gasic GJ. Thrombospondin a potentiator of tumour cell metastasis. Cancer Res. 1987; 47; 4130-4133.
29. Terranova VP, Williams JE, Liotta LA, Martin GR. Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. Science 1984; 226; 982-985.
30. Browning PJ, Sechler JMG, Kaplan M et al. Identification and culture of Kaposi's sarcoma-like spindle cells from peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls. Blood 1944; 84; 2711-2720.
31. Chang Y, Cesarman K, Pessin MS et al. Identification of Herpes-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1944; 266; 1865-1869.
32. Schalling M, Ekman M, Kaaya E, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nature Medicine 1995; 1; 707-708.
33. Morfeldt L, Torssander J. Long-term remission of Kaposi's sarcoma following foscarnet treatmenl. Scand. J. Infect. Dis. 1994; 26; 749-752.